Vaxcell-Bio Therapeutics
Biotech firm developing immunotherapies for oncology and other diseases.
323990 | KO
Overview
Corporate Details
- ISIN(s):
- KR7323990002
- LEI:
- Country:
- South Korea
- Address:
- 전라남도 화순군 화순읍 산단길 12-55, 화순군
- Website:
- https://vaxcell-bio.com/en/
- Sector:
- Manufacturing
Description
Vaxcell-Bio Therapeutics is a biotechnology company specializing in the research and development of innovative immunotherapies. The company's primary focus is on oncology, developing a pipeline of cell-based and protein-based treatments, including immune cell therapies and targeted protein-degrading therapeutics. In addition to its core focus on cancer, Vaxcell-Bio is expanding its research into other areas, such as developing drug delivery system (DDS)-based therapies for conditions like macular degeneration.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-02-18 00:00 |
기타경영사항(자율공시) ( 소규모합병 승인 이사회 결의(주주총회 갈음) 결과보고)
|
Korean | 10.2 KB | ||
| 2025-02-05 00:00 |
[기재정정]주식등의대량보유상황보고서(일반)
|
Korean | 507.5 KB | ||
| 2025-02-04 00:00 |
[기재정정]주식매수선택권부여에관한신고
|
Korean | 20.8 KB | ||
| 2025-02-04 00:00 |
[기재정정]주식매수선택권부여에관한신고
|
Korean | 23.6 KB | ||
| 2025-02-04 00:00 |
매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 11.6 KB | ||
| 2025-01-20 00:00 |
주요사항보고서(회사합병결정)
|
Korean | 221.5 KB | ||
| 2025-01-14 00:00 |
기업설명회(IR)개최
|
Korean | 6.7 KB | ||
| 2025-01-09 00:00 |
[기재정정]투자판단관련주요경영사항 (박스루킨15주 (Vaxleukin15 inj) 품목허가변경신청 (적응증 확대 및 유…
|
Korean | 19.9 KB | ||
| 2024-12-26 00:00 |
합병등종료보고서(합병)
|
Korean | 18.6 KB | ||
| 2024-12-13 00:00 |
주주명부폐쇄기간또는기준일설정
|
Korean | 4.1 KB | ||
| 2024-12-02 00:00 |
투자판단관련주요경영사항 (박스루킨15주 (Vaxleukin15 inj) 품목허가변경신청 (적응증 확대 및 유효기간, 제…
|
Korean | 17.4 KB | ||
| 2024-11-20 00:00 |
기타경영사항(자율공시) (소규모합병 승인 이사회 결의(주주총회 갈음) 결과보고)
|
Korean | 10.1 KB | ||
| 2024-11-20 00:00 |
[기재정정]기타경영사항(자율공시) (소규모합병 승인 이사회 결의(주주총회 갈음) 결과보고)
|
Korean | 13.4 KB | ||
| 2024-11-14 00:00 |
분기보고서 (2024.09)
|
Korean | 1.3 MB | ||
| 2024-10-25 00:00 |
[기재정정]주식등의대량보유상황보고서(일반)
|
Korean | 917.0 KB |
Automate Your Workflow. Get a real-time feed of all Vaxcell-Bio Therapeutics filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Vaxcell-Bio Therapeutics
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Vaxcell-Bio Therapeutics via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
